Very early improvements in the wrist and hand assessed by power doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis

Arthritis Care and Research

Volumn 63, Issue 10, 2011, Pages 1477-1481

  Kume, Kensuke ^a   Amano, Kanzo ^a   Yamada, Susumu ^a   Hatta, Kazuhiko ^b   Kuwaba, Noriko ^c   Ohta, Hiroyuki ^d  

^a Hatta Clinic ^*

^b Hatta Clinic   (Japan)

^c IGL School   (Japan)

^d IGL School   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TOCILIZUMAB;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; FEMALE; HAND; HUMAN; MALE; METACARPOPHALANGEAL JOINT; PROXIMAL INTERPHALANGEAL JOINT; RHEUMATOID ARTHRITIS; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TREATMENT RESPONSE; WRIST;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; FINGER JOINT; HUMANS; JAPAN; MALE; METACARPOPHALANGEAL JOINT; METHOTREXATE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; WRIST JOINT;

EID: 81255178493     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20537     Document Type: Article

References (20)

1. Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J heumatol 2003; 30:966-71.
2. Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 2005;64: 375-81.
3. Naredo E, Moller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti- tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008;58:2248-56.
4. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Ramus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomized trial. Lancet 2008;371:987-97.
5. Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor biologicals: results from a 24-week multicentre randomized placebocontrolled trial. Ann Rheum Dis 2008;67:1516-23.
6. Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum 2010;39:425-41.
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
9. Rubin JM, Adler RS, Fowlkes JB, Spratt S, Pallister JE, Chen JF, et al. Fractional moving blood volume: estimation with power Doppler US. Radiology 1995;197:183-90.
10. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001;60:641-9.
11. D'Agostino MA, Conaghan PG, Naredo E, Aegerter P, Iagnocco A, Freeston JE, et al. The OMERACT Ultrasound Task Force: advances and priorities. J Rheumatol 2009;36:1829-32.
12. Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Sauden A, et al. Smallest detectable difference in radiological progression. J Rheumatol 1999;26:731-9.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
14. Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, et al. Minimal clinically important differences: review of methods. J Rheumatol 2001;28:406-12.
15. Hammer HB, Sveinsson M, Kongtorp AK, Kvien TK. A 78- joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment. Ann Rheum Dis 2010;69:1349-51.
16. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
17. Smolen JS, Aletaha D. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis Rheum 2011;63:43-52.
18. Scire CA, Meenagh G, Filippucci E, Riente L, Delle Sedie A, Salaffi F, et al. Ultrasound imaging for the rheumatologist. XXI. Role of ultrasound imaging in early arthritis. Clin Exp Rheumatol 2009;27:391-4.
19. Naredo E, Moller I, Acebes C, Batlle-Gualda E, Brito E, de Aqustin JJ, et al. Three-dimensional volumetric ultrasonography: does it improve reliability of musculoskeletal ultrasound? Clin Exp Rheumatol 2010;28:79-82.
20. Filippucci E, Meenagh G, Delle Sedie A, Salaffi F, Riente L, Lagnocco A, et al. Ultrasound imaging for the rheumatologist. XX. Sonographic assessment of hand and wrist joint involvement in rheumatoid arthritis: comparison between two- and three-dimensional ultrasonography. Clin Exp Rheumatol 2009;27:197-200.